Axsome Therapeutics, Inc. ($AXSM)
Filing Information
| Accession Number | 0001193125-26-083586 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 28, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
106,134
Total Value
$5,827,817.94
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Feb 26, 2026 | Exercise/Conversion | 35,378 | $2.85 | $100,827.30 | 35,378 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Feb 26, 2026 | Sale | 35,378 | $161.88 | $5,726,990.64 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Feb 26, 2026 | Exercise/Conversion | 35,378 | $0.00 | $0.00 | 0 | Direct | โ | View Details |